ArticleEuropean endocrinology2015
Insulin Glulisine in Pregnancy - Experience from Clinical Trials and Post-marketing Surveillance.
Article in European endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- [Management of hyperglycemia in pregnancy (Update 2026)].Wiener klinische Wochenschrift · 2026Review
- [Clinical practice recommendations for diabetes in pregnancy (Update 2023)].Wiener klinische Wochenschrift · 2023Article
- [Gestational diabetes mellitus (Update 2023)].Wiener klinische Wochenschrift · 2023Article
- Maternal diabetes negatively impacts fetal health.Open biology · 2022Review
- Diabetes: how to manage gestational diabetes mellitus.Drugs in context · 2022Review
- [Gestational diabetes mellitus (Update 2019)].Wiener klinische Wochenschrift · 2019Review
- [Clinical practice recommendations for diabetes in pregnancy (Update 2019)].Wiener klinische Wochenschrift · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnancies complicated by gestational diabetes or pre-existing type 1 or type 2 diabetes mellitus are associated with a higher rate of adverse outcomes compared with pregnancies in the background population. These outcomes include miscarriage, pre-term delivery, pre-eclampsia, perinatal mortality and congenital malformations. Insulin glulisine (Apidra
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.